Clinical Trial Update: Iodine-131 Anti-B1 Antibody Consolidation for Patients With Non-Hodgkin's Lymphoma Following First-line CHOP [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating consolidation with iodine-131 labeled anti-B1 antibody after first-line CHOP therapy in patients with non-Hodgkin lymphoma; results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Iodine-131 anti-B1 antibody (iodine-131 labeled anti-B1 antibody)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lymphoma, Non-Hodgkin | Phase 2 | Status: COMPLETED | Results posted: 2013-09-12